Dr. Vijay K. Mittal, MD

Dr. Mittal practices at Central Florida Heart Center in Ocala, Florida.

Dr. Mittal's NPI, 1821026022, was assigned on June 28, 2006. Dr. Mittal graduated from All India Institute of Medical Sciences in 1979. Dr. Mittal holds Florida license ME51848.

Dr. Mittal's primary practice is Central Florida Heart Center, at 3310 Sw 34th St, Ocala, FL 34474 in Marion County. The practice phone is (352) 873-0707.

Dr. Mittal's primary practice is Central Florida Heart Center in Ocala, Florida. Dr. Mittal is also affiliated with HCA Florida Ocala Hospital. The medical group on file is Central Florida Heart Center. Dmand AI also links Dr. Mittal to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mittal practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mittal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mittal is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Mittal's licenses on file in 4 states: Florida, New Jersey, New York and Maryland.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. Mittal treats.

CMS data shows 4,791 Medicare services from Dr. Mittal across 27 procedure codes in 2024, for 1,000 Medicare patients. Medicare paid $361,241 for them.

CMS counts 1,000 Medicare patients who saw Dr. Mittal in 2024. The largest group is 75 to 84, with 438 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mittal's median patient age at 76, with 53% women.

In 2024, Dr. Mittal wrote 7,015 Medicare Part D claims for 727 patients. 86% of them were for generic drugs. CMS names the drug for 6,640 of them, across 90 drugs with 11 or more claims each, at $924,691 in total drug cost. In 2023, CMS named 6,273 claims across 82 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Mittal for performance year 2024, reported as part of a group. Dr. Mittal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 87 papers to Dr. Mittal, published from 2010 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Education, Medical, Graduate, General Surgery and Internship and Residency. Dr. Mittal has published most often in Am Surg. Dr. Mittal's most frequent co-authors are Jasneet S. Bhullar, MD, Francisco Igor Bulcao De Macedo, MD and Sumet Silapaswan, MD.

CMS Open Payments shows 205 general payments to Dr. Mittal from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,322.

Dmand AI lists 1 award for Dr. Mittal.

Dr. Mittal graduated from All India Institute of Medical Sciences in 1979. Dr. Mittal is a member of ACC.

Dr. Mittal is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.